Fred Alger Management, LLC Krystal Biotech, Inc. Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$96.0 - $128.29 $686,400 - $917,273
-7,150 Reduced 4.27%
160,335 $19.9 Million
Q3 2023

Nov 14, 2023
BUY
$108.51 - $130.22 $17.8 Million - $21.3 Million
163,928 Added 4608.6%
167,485 $19.4 Million
Q2 2023

Aug 14, 2023
BUY
$78.48 - $130.32 $279,153 - $463,548
3,557 New
3,557 $417,000

Others Institutions Holding KRYS

# of Institutions
310
Shares Held
24.4M
Call Options Held
483K
Put Options Held
364K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.89B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email